SCOTUS decision in Hobby Lobby case reaches beyond contraception.
Lung-MAP and the National Lung Matrix Trial aim to deliver precision-based, FDA-approved treatment to patients with lung cancer by using a streamlined trial design that allows flexibility for the investigators, patients, and drug manufacturers.
With the cost of cancer care rising, an ASCO task force has been established to create a framework for assessing relative value of cancer treatment.
Muhammad Rizvi, MD, discusses lung cancer research from ASCO 2014.
Barbara Ann Burtness, MD
Steven Cohen, MD
E. David Crawford, MD
Don S. Dizon, MD, FACP
Jeffrey M. Farma, MD
Edith A. Perez, MD
Neal D. Shore, MD, FACS
Mark A. Socinski, MD
Mario Sznol, MD
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|